Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-18-285823
Filing Date
2018-09-27
Accepted
2018-09-27 17:21:45
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d553197d424b4.htm 424B4 2347902
2 GRAPHIC g553197g01h12.jpg GRAPHIC 58979
3 GRAPHIC g553197g10b20.jpg GRAPHIC 68932
4 GRAPHIC g553197g16p90.jpg GRAPHIC 86806
5 GRAPHIC g553197g20j01.jpg GRAPHIC 53079
6 GRAPHIC g553197g21v93.jpg GRAPHIC 99935
7 GRAPHIC g553197g33e47.jpg GRAPHIC 77286
8 GRAPHIC g553197g39v42.jpg GRAPHIC 80049
9 GRAPHIC g553197g45v80.jpg GRAPHIC 77787
10 GRAPHIC g553197g47y05.jpg GRAPHIC 76201
11 GRAPHIC g553197g51k44.jpg GRAPHIC 108630
12 GRAPHIC g553197g55s24.jpg GRAPHIC 65548
13 GRAPHIC g553197g61j23.jpg GRAPHIC 32072
14 GRAPHIC g553197g62l95.jpg GRAPHIC 52903
15 GRAPHIC g553197g90x13.jpg GRAPHIC 81259
16 GRAPHIC g553197g96u56.jpg GRAPHIC 77546
  Complete submission text file 0001193125-18-285823.txt   3860506
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA INC (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-227103 | Film No.: 181091833
SIC: 2836 Biological Products, (No Diagnostic Substances)